Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma – targets for therapeutic intervention?

Jöhrer, K; Hofbauer, SW; Zelle-Rieser, C; Greil, R; Hartmann, TN; Expert Opin Biol Ther. 2012; 12(4):425-441

Lysine residue at position 22 of the AID protein regulates its class switch activity.

Geisberger, R; Huemer, M; Gassner, FJ; Zaborsky, N; Egle, A; Greil, R; PLoS One. 2012; 7(2):e30667

First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.

Bergh, J; Bondarenko, IM; Lichinitser, MR; Liljegren, A; Greil, R; Voytko, NL; Makhson, AN; Cortes, J; Lortholary, A; Bischoff, J; Chan, A; Delaloge, S; Huang, X; Kern, KA; Giorgetti, C; J Clin Oncol. 2012; 30(9):921-929

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study.

Auberger, J; Lass-Flörl, C; Aigner, M; Clausen, J; Gastl, G; Nachbaur, D; J Antimicrob Chemother. 2012; 67(9):2268-2273

Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.

Dubsky, PC; Jakesz, R; Mlineritsch, B; Pöstlberger, S; Samonigg, H; Kwasny, W; Tausch, C; Stöger, H; Haider, K; Fitzal, F; Singer, CF; Stierer, M; Sevelda, P; Luschin-Ebengreuth, G; Taucher, S; Rudas, M; Bartsch, R; Steger, GG; Greil, R; Filipcic, L; Gnant, M; J CLIN ONCOL. 2012; 30(7): 722-728.

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkinxxxs lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

Engert, A; Haverkamp, H; Kobe, C; Markova, J; Renner, C; Ho, A; Zijlstra, J; Kral, Z; Fuchs, M; Hallek, M; Kanz, L; Dohner, H; Dorken, B; Engel, N; Topp, M; Klutmann, S; Amthauer, H; Bockisch, A; Kluge, R; Kratochwil, C; Schober, O; Greil, R; Andreesen, R; Kneba, M; Pfreundschuh, M; Stein, H; Eich, HT; Muller, RP; Dietlein, M; Borchmann, P; Diehl, V LANCET. 2012; 379(9828): 1791-1799.

Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target

Johrer, K; Obkircher, M; Neureiter, D; Parteli, J; Zelle-Rieser, C; Maizner, E; Kern, J; Hermann, M; Hamacher, F; Merkel, O; Wacht, N; Zidorn, C; Scheideler, M; Greil, R J MOL MED. 2012; 90(6): 681-693.

Prognostic Value of Number of Removed Lymph Nodes, Number of Involved Lymph Nodes, and Lymph Node Ratio in 7502 Breast Cancer Patients Enrolled onto Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)

Tausch, C; Taucher, S; Dubsky, P; Seifert, M; Reitsamer, R; Kwasny, W; Jakesz, R; Fitzal, F; Filipcic, L; Fridrik, M; Greil, R; Gnant, M ANN SURG ONCOL. 2012; 19(6): 1808-1817.

Dose-Intensification in Early Unfavorable Hodgkinxxxs Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

von Tresckow, B; Plutschow, A; Fuchs, M; Klimm, B; Markova, J; Lohri, A; Kral, Z; Greil, R; Topp, MS; Meissner, J; Zijlstra, JM; Soekler, M; Stein, H; Eich, HT; Mueller, RP; Diehl, V; Borchmann, P; Engert, A J CLIN ONCOL. 2012; 30(9): 907-913.

Tissue-Sparing Application of the Newly Proposed IASLC/ATS/ERS Classification of Adenocarcinoma of the Lung Shows Practical Diagnostic and Prognostic Impact

Sterlacci, W; Savic, S; Schmid, T; Oberaigner, W; Auberger, J; Fiegl, M; Tzankov, A AM J CLIN PATHOL. 2012; 137(6): 946-956.